Trial intelligence / Profile preview

Radiolabeled AL-335 metabolism and excretion study alone and with odalasvir plus simeprevir

NL-OMON44638Phase 1Withdrawn

Sponsor

Janssen Pharmaceutical

Start

Jul 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1